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Abstract
Background: For many childhood cancer survivors follow-up care is important long after treatment completion. We aimed
to describe the availability and characteristics of long-term follow-up programs (LTFU) across Europe, their content and
aims, their problems, and to assess opinions on different models of LTFU.
Methodology/Principal Findings: We asked 179 pediatric oncology institutions in 20 European countries to complete an
online survey on LTFU available at their institution. Of 110 respondents (62% response), 66% reported having LTFU for
pediatric survivors, 38% for adult survivors of childhood cancer. Availability varied widely across European regions, from 9%
of institutions in Northern Europe reporting LTFU for adult survivors to 83% of institution on the British Isles reporting LTFU
for pediatric survivors. Pediatric and adult LTFU were usually located in pediatric hospitals and run by pediatric oncologists.
Content of follow-up included screening for adverse outcomes and health education. Important problems included lack of
time, personnel and funding. Most institutions without LTFU reported that they would like to offer a program (86%).
Conclusion/Significance: Despite general agreement on the need of follow-up care, there is still a lack of well-organized
LTFU for survivors of childhood cancer across Europe.
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Introduction
Specialists promote long-term follow-up programs for childhood
cancer survivors including comprehensive, evidence-based health
care and education (LTFU). Relevant guidelines have been
published [1–5] and the National Cancer Survivorship Initiative
(NCSI) recently recommended that new models of follow-up care
should be implemented [6,7]. All these efforts address the problem
of cancer- and treatment-induced late adverse outcomes. Around
two-thirds of childhood survivors develop late effects, even long
after treatment is completed, including a wide range of physical
and psychosocial problems, such as endocrine or cardiac
problems, second malignancies, psychological distress, educational
problems or increased late mortality [8–12].
There is little data on the availability of LTFU for childhood
cancer survivors in Europe. In other regions, surveys indicated
that only some survivors regularly attend well-organized LTFU. In
a recent survey among institutions of the Children’s Oncology
Group (COG), located predominantly in the USA, 59% of
respondents reported that LTFU is available to pediatric survivors,
and 47% to adult survivors [13]. In a Canadian survey, the
respective proportions were 87% and 53% [14].
To describe the availability of LTFU for pediatric and adult
survivors of childhood cancer, we performed a questionnaire
survey among European institutions treating children with cancer.
Our aims were to: 1) describe the availability and characteristics of
LTFU for survivors across Europe; 2) describe the content and
aims; 3) and problems of LTFU; and 4) assess opinions on optimal
LTFU.
Methods
Ethics Statement
All respondents agreed to take part in this study. According to
local and international guidelines on ethics considerations in
research involving human participants, this survey among
physicians on health care system issues does not raise any ethical
concerns [15,16]. Therefore, formal ethics approval from an
ethical committee was deemed unnecessary.
Sample/Procedure
We aimed to address all institutions treating patients with
childhood cancer across Europe. Because of a recent survey on
follow-up care in France [17] and a planned study in Germany, we
did not contact the institutions in these two countries. Countries
were grouped according to the United Nations definition of
European regions, except that we grouped the UK and Ireland
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into the ‘‘British Isles’’ [18]. This allowed to better differentiate
between health systems.
Through web-search and contact with national representatives
of the pan-European PanCare late effects network (www.pancare.
eu) we compiled a list of all institutions in 20 European countries
where children with cancer are treated. We developed an online
questionnaire and sent an e-mail inviting heads of the centers to
complete the password-protected online questionnaire. If they felt
they were not the best person to complete it, we asked center heads
to forward the e-mail to the person responsible for follow-up care
at their institution. If we did not receive the completed
questionnaire within two weeks, we sent an e-mail reminder. If
there was still no response, we asked national PanCare
representatives to prompt the center head to respond.
Questionnaire
We defined long-term follow-up programs (LTFU) as: ‘‘A model
of specialized care dedicated to follow-up of childhood cancer
survivors. Specialized care may contain comprehensive, evidence-
based health care and education for survivors of childhood cancer.
Follow-up only done for participants of clinical trials during trial
follow-up should not be included in this definition’’.
The questionnaire comprised five sections: 1) information on
the respondents/institution; 2) follow-up available at institution; 3)
LTFU for survivors in pediatric care (,16–20 years of age); 4)
LTFU for adult survivors (age .16–20 years); and, 5) guidelines
used for follow-up.
(Questionnaire S1)
Our first aim was to assess the availability and describe the
characteristics of LTFU for pediatric and adult survivors across
Europe. To address it, we asked respondents if a follow-up
program/clinic was available to pediatric or adult survivors of
childhood cancer, respectively. We also asked all respondents
about their professional background and the characteristics of their
institution and LTFU (frequency and location of program/clinic,
staff and survivors involved).
Table 1. Institutions contacted and responding, and programs available.
Region Country
Total number of
institutions
contacted Responding institutions Institutions with LTFU
for pediatric survivorsa for adult survivorsa
n n % n % n %
British Isles 21 15 71 10 83 8 67
Ireland 1 1 100 1 100 0 0
UK 20 14 70 9 82 8 73
Northern Europe 16 11 69 7 64 1 9
Denmark 2 1 50 1 100 0 0
Finland 5 3 60 3 100 0 0
Lithuania 1 1 100 0 0 0 0
Norway 3 1 33 0 0 0 0
Sweden 5 5 100 3 60 1 20
Southern Europe 83 47 57 22 56 17 45
Greece 4 4 100 3 100 2 67
Italy 54 25 46 12 60 12 63
Portugal 1 0 0 na na
Slovenia 1 1 100 1 100 1 100
Spain 23 17 74 6 40 2 13
Western Europe 30 20 67 13 72 7 39
Austria 5 3 60 1 50 1 50
Belgium 8 4 50 3 75 1 25
Netherlands 8 4 50 4 100 4 100
Switzerland 9 9 100 5 63 1 13
Eastern Europe 29 17 59 9 69 2 17
Czech Republic 2 2 100 1 100 1 100
Hungary 8 2 25 2 100 0 0
Poland 16 11 69 5 63 1 14
Slovak Republic 3 2 67 1 50 0 0
Total 179 110 61 61 66 (CI:55–75) 35 38 (CI: 28–49)
Abbreviations: LTFU, long-term follow-up program; na, not applicable; CI, 95% Confidence Interval.
asome respondents to the questionnaire did not answer the question on LTFU (available respondents for pediatric programs: N= 93; for adult programs: N = 91).
doi:10.1371/journal.pone.0053201.t001
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Our second aim, to assess content and aims of follow-up, was
addressed by asking if those running the LTFU clinic used relevant
guidelines, and if they screened for certain problems and/or
educated survivors with specific information.
For our third aim, to describe problems of the LTFU, we
provided a list of possible problems and asked respondents to tick
the problems they encountered in their LTFU.
Our fourth aim, assessing different models of follow up, was
addressed by asking which staff should ideally be involved in
follow-up care. We also asked respondents to rank different models
for organizing follow-up care, adapted from Wallace and
colleagues [19], according to how optimal respondents considered
them to be (1 = least, 6 =most optimal).
Analyses
Analyses were performed with Stata 12.0 (Stata Corporation,
Austin, Texas). We used descriptive analyses with chi2-tests for
most outcomes. We used t-tests to compare the mean of the
participants’ estimation of the proportion of survivors attending
follow-up at different time periods after treatment. We used
separate linear regressions to compare the age range of survivors
involved and staff that should ideally be involved in follow-up care
(dependent variables) between European regions (independent
variable). To compare ratings of optimal models of follow-up care
we used Hotelling’s T-square statistic to test for the overall
differences between means of all models of care and Student’s t-
test for post-hoc analyses to tests for differences between two
specific models.
Results
Respondents
We contacted 179 institutions in 20 European countries. Of
these, 110 (62%) completed at least section one of the question-
naire (Table 1). Most respondents were pediatric oncologists
(n = 82, 88%; the percentage given always reflects the respective
proportion of institutions out of those institutions responding to the
specific question), worked in a university hospital’s pediatric
oncology department (n = 83, 89%), and were involved both in
acute care (n = 92, 99%) and follow-up care (n = 91, 98%). These
results did not differ significantly between institutions with or
without LTFU for pediatric or adult survivors (Table 2).
Availability and Characteristics
Almost all respondents (n = 90, 97%) indicated that there is
some form of follow-up available for survivors. In total, 63 (68%)
institutions reported having LTFU available; 66% (n= 61) for
pediatric survivors, and 38% (n= 35) for adult survivors.
Proportions of institutions providing LTFU varied considerably
between European countries and regions (Table 1). For pediatric
survivors LTFU was available in all regions, with proportions
between 56% (Southern Europe) and 83% (British Isles). For adult
survivors the availability varied considerably, with proportions
between 9% (Northern Europe) and 67% (British Isles). Among 29
respondents who had LTFU for neither pediatric nor adult
survivors, 25 (86%) stated that they would like a LTFU at their
institution.
Frequency and location. LTFU clinics were offered weekly
in most institutions (for pediatric survivors: n = 25, 49%; for adult
survivors: n = 11, 39%), more frequently in 14 (28%) and 7 (25%)
institutions, respectively, and less frequently in 7 (14%) and 6
(21%) institutions, respectively. Most institutions sent survivors an
appointment date for their follow-up (LTFU for pediatric
survivors: n = 52, 90%; LTFU for adult survivors: n = 24, 75%);
others sent an invitation to contact the clinic for an appointment
(n = 7, 12%; n= 7, 22%) or left it to the survivor to request an
appointment (n = 1, 2%; n= 1, 3%; multiple responses were
permitted). Most LTFU clinics for pediatric survivors were
situated in a pediatric hospital (n = 56, 98%); 18 LTFU clinics
for adult survivors (56%) were situated in a pediatric hospital, and
14 in an adult hospital (44%).
Staff involved. LTFU for pediatric survivors was most often
run by a pediatric oncologist (n = 36, 64%; in 5 additional
institutions [9%] the program was run jointly by a pediatric and
medical oncologist). One program was run by a medical oncologist
(2%), one by a nurse (2%) and 13 by various combinations of
specialists (23%). LTFU for adult survivors was also most often run
by a pediatric oncologist (n = 13, 46%; in 1 additional institution
Table 2. Characteristics of responding institutions.
Institution without LTFU Institution with LTFU
N % N % p
Total 30 100 63 100
Professional background
Pediatric oncologist/haematologist 28 93 54 86 0.288
Other 2 7 9 14
Type of institution (several possible)
Pediatric Oncology/Haematology, University Hospital 29 97 54 86 0.265
Pediatric Oncology/Haematology, Other Hospital 1 3 7 11
Adult Ward, University Hospital 0 0 2 3
In which areas of care are you involved (several possible)
Acute care of newly diagnosed patients 30 100 62 98 0.488
Short term FU (,5 years after diagnosis) 30 100 61 97 0.324
Long term FU (.5 years after diagnosis) 28 93 59 94 0.954
Other areas* 4 13 10 16 0.749
Abbreviations: LTFU, long-term follow-up programmes; *other areas: e.g. palliative care, stem cell transplantation, transition.
doi:10.1371/journal.pone.0053201.t002
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[4%] the program was run jointly by a pediatric and medical
oncologist). Six programs were run by a medical oncologist (21%),
one by a nurse (4%) and 5 by various combinations of specialists
(18%).
In most cases, the pediatric oncologist who treated the patient
originally was involved in LTFU, both for pediatric and adult
survivors (n = 47, 81%; n= 20, 63%). Other staff were involved in
all but one LTFU (98%, Figure 1).
Survivors attending. Throughout the first 5 years after
diagnosis, respondents estimated that almost all survivors attended
LTFU (mean=88%, SD=4.4), but the number decreased to 70%
over the next 5–10 years (SD=7.8) and to 48% .10 years after
diagnosis (SD=6.9, all p#0.001; Figure 2). Although intended
primarily for pediatric survivors, many institutions included older
patients in their follow-up program and the upper age limit varied
considerably (mean= 27.1, SD=15.4, range: 14 to ‘‘no age
limit’’), even within countries (e.g. UK: mean= 30.1, SD=14.7,
range: 18–60; Italy: mean= 28.1, SD=8.5, range: 16–40; Spain:
mean=22.2, SD=8.3, range: 14–38). However, there was no
significant difference between European regions (F(4,51) = 0.37,
p = 0.827).
Eventually, 70% of institutions (n = 39) discharged pediatric
survivors, mostly to GPs (n = 24, 42%), adult oncologists (n = 21,
37%) or a transition program (n= 10, 18%; multiple responses
Figure 1. Staff involved in LTFU and staff desired in an optimal model of follow-up care. LTFU: long-term follow-up program.
doi:10.1371/journal.pone.0053201.g001
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were permitted). Among the reasons for discharge were that the
patient had reached a certain age (n = 28, 68%), that patients did
not want to continue LTFU (n= 11, 27%), lack of resources (n = 3,
7%), and the increasing number of survivors (n = 2, 5%).
Adult survivors started attending adult LTFU from a median
age of 18 years (SD=4.6, range: 16–40). Survivors were eventually
discharged in 45% of programs (n = 14), mostly to GPs (n = 9,
28%) or adult oncologists (n = 6, 19%; several responses possible).
Among the reasons for discharge were that patients were
considered ‘‘low risk’’ for late effects (n = 8; 44%), patients did
not want to continue LTFU (n= 6, 33%), other specialists were
more appropriate (n = 5, 28%), patients had reached a certain age
(n = 4, 22%), and attending a pediatric ward was an obstacle
(n = 2, 11%).
Content of LTFU
Most respondents reported that they used guidelines to follow
both pediatric and adult survivors (n = 48, 89%; n= 25, 81%).
Institutions screened for cancer recurrence (Figure 3), late effects,
second malignant neoplasms, and psychosocial problems. They
also educated survivors about their previous disease and treatment,
potential future health problems and future health behaviors.
There was no difference between European regions (all p.0.05).
Detailed results are presented in Table S1. A written summary of
the cancer treatment was always provided to survivors by 60%
(n= 36, pediatric LTFU) and 44% (n= 15, adult LTFU) of
institutions, respectively. Many gave general information about
late effects to all survivors (n = 34, 64%; n= 21, 68%), while most
provided patient-specific information to all survivors (n = 51, 85%;
n= 29, 85%).
Problems Encountered in LTFU
The most frequently reported problems in LTFU for pediatric
survivors were on the provider side (Figure 4). Problems on the
survivor side were less frequent but still concerned a considerable
number of institutions. There was no difference between European
Figure 2. Survivors involved in LTFU: Estimated proportion of pediatric survivors attending follow-up,5, 5–10 and .10 years after
diagnosis. LTFU: long-term follow-up program; CNS: central nervous system.
doi:10.1371/journal.pone.0053201.g002
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regions (all p.0.05). Detailed results are presented in Table S2.
In LTFU for adult survivors, all problems were more common
than in LTFU for pediatric survivors, but especially survivor-
related problems.
Optimal Care
Staff. When asked about who should ideally care for survivors
most respondents agreed that a pediatric oncologist should be
involved in LTFU for pediatric (n = 57, 100%) and adult survivors
(n = 25, 81%; Figure 1). However, in addition medical oncolo-
gists, specialist nurses, general practitioners and social workers
were desired often but not available for LTFU.
Organizational model. Follow-up by a multidisciplinary
team was rated higher than the other theoretical models of LTFU
proposed for both pediatric and adult survivors (mean= 5.3,
SD=1.6 and mean= 5.4, SD=1.5, respectively). Other proposed
models were: pediatric oncologist (mean= 5.2, SD=1.3;
mean= 4.0, SD=1.7), specialist nurse (mean= 3.6, SD=1.7;
mean=4.0, SD=1.8), medical oncologist (mean=3.4, SD=1.8;
mean=3.7, SD=1.7), and general practitioner (mean=3.1,
SD=1.5; mean= 3.8, SD=1.7) (Figure 5). In LTFU for
pediatric survivors, there were significant differences between
European regions in their rating of the multidisciplinary team
(F(4,54) = 3.62; p = 0.011) and nurse-led care (F(4,54) = 5.60;
p,0.001). The multidisciplinary team was rated lowest in the
Nordic countries, and nurse-led care was rated high only in the
British Isles. Detailed results on the level of countries are presented
in Table S3.
Discussion
Our overview of follow-up programs showed that there is still a
lack of LTFU for childhood cancer survivors in Europe. While
66% of institutions report LTFU for their pediatric survivors, only
38% have a LTFU available for adult survivors. However, even
institutions with established LTFU also reported a number of
Figure 3. Content of pediatric and adult LTFU. LTFU: long-term follow-up program.
doi:10.1371/journal.pone.0053201.g003
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institution- and survivor-related problems, particularly in pro-
grams for adult survivors. Most (86%) of the institutions without
LTFU would like to provide this form of follow-up care to their
survivors.
Surveys among childhood cancer survivors in Europe and
elsewhere indicate that only some survivors receive high quality
follow-up care [20–23]. LTFU does not necessarily equate to high
quality care, and less formal LTFU might provide high quality
care to individual survivors. However, well-organized LTFU will
become more important with the ever increasing number of
childhood cancer survivors.
The availability of LTFU across European regions varied
between 9% and 83%. This could have different reasons. Access to
funding, space and trained professionals with dedicated time for
LTFU may differ across institutions and countries. On the British
Isles we found a high proportion of institutions that provided
LTFU. National guidelines available in England and Scotland
[3,6,7,24] may provide guidance and support to institutions
wishing to provide LTFU in a formal setting.
Comparison with other Studies
The availability of LTFU for pediatric survivors in Europe
(66%) is comparable to the USA and Canada, but is lower for
adult survivors (38%). A recent study reported that 59% of
institutions of the COG, predominantly in the USA, had LTFU
for pediatric and 47% for adult survivors [13]. In an earlier study
in the USA on programs for adult survivors, 44% of institutions
stated they had a program available [25]. In Canada, the
respective proportions were .80% and 53% [14,26].
We found that pediatric oncologists are running LTFU for
pediatric and adult survivors in most institutions, supporting
previous findings from USA and Canada [14,26,27]. Respondents
agreed that pediatric oncologists should be involved in LTFU.
This is in contrast with results from a study of pediatric oncologists
in the USA, where only 38% reported that they wanted to be the
doctor of a survivor for ‘‘as long as possible’’ [28].
Specialist nurses were available in all comprehensive follow-up
programs described by Aziz and colleagues [27], and in most of
the institutions (72%) participating in a recent survey among the
Figure 4. Problems encountered in LTFU. LTFU: long-term follow-up program.
doi:10.1371/journal.pone.0053201.g004
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COG [13]. For Europe, we found that less than half institutions
routinely involved nurses in their program. Indeed, lack of a
dedicated nurse practitioner was listed as a major disadvantage by
respondents to our survey.
We asked respondents to rate different models of follow-up
adapted from Wallace and colleagues [19]. Our data showed that
GP- or nurse-led follow-up, which could be suitable for survivors
with a low risk for late effects, were considerably less favored than
follow-up by a multidisciplinary team, or by a pediatric oncologist in
LTFU for pediatric survivors. However, a combination of models
for survivors according to their risk for late effects might represent a
future solution to many of the problems reported in our survey.
Most programs use follow-up guidelines, but around one in four
reported providing little or no patient education about previous
illness, treatment, late effects or health behavior. This might be a
reason for attrition in follow up care. The proportion using
guidelines was similar to that reported in a Canadian study (88%)
[26]. Despite recommendations [29–31], provision of treatment
summaries was relatively low: fewer than two thirds of all
institutions with programs provide such a summary. This is
similar to findings from France [32] and is especially notable
because studies have found that survivors are relatively ignorant
about their former disease and treatment [33–35]. Survivors are
often unaware that follow-up is necessary. This lack of knowledge
has been reported to be a major contributor to limited follow-up
attendance [21]. Medical screening was a frequent activity during
consultations, but provision of education of and information to
survivors was less frequent and similar to findings from Canada
[26]. This might not be sufficient, especially when considering
survivors’ need for information and education [36,37].
Strengths and Limitations
This is the first multi-country overview of follow-up programs in
Europe, and by far the most comprehensive. We provided detailed
results on region and country level, allowing the reader to
understand the considerable variability across Europe. We were
able to contact almost all institutions treating children with cancer
in Europe. However, we were not able to include data from two
large countries (Germany and France) and some smaller countries
not participating in PanCare, but information on follow-up care
was recently assessed in France [17,32] and should soon be
available for Germany.
Self-report questionnaires have some inherent weaknesses.
Because the survey was based on a self-report questionnaire,
social desirability may have played a role in the description of the
respondent’s own LTFU. Similarly, the nature of LTFU was self-
categorized, although we gave a specific definition in the
questionnaire. Participants’ estimated percentages have to be
interpreted with caution and should not be understood as exact
values in clinical practice.
Conclusion
Long-term follow-up for childhood cancer patients is a necessary
part of care for most childhood cancer patients after completion of
treatment. Well-organized follow-up programs improve the quality
of care for the increasing number of survivors. Our study showed
that many European countries do not provide enough LTFU.
Despite general agreement on the need for LTFU, and the existence
of relevant guidelines, three of five European institutions do not
implement such programs for adult survivors, and one of three does
not provide them for pediatric survivors of childhood cancer. This is
a potential disservice to former patients. Thanks to close interna-
tional collaboration of pediatric oncologists and other specialists, as
practiced in the PanCare Network and the PanCare SurFup project
(www.pancare.eu), European guidelines for LTFU will soon be
available. As in the British Isles, institutions may then profit from
available knowledge and experience, and build their own program
according to their needs and those of their survivors.
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